FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2939452829> ?p ?o ?g. }

• W2939452829 endingPage "1058" @default.
• W2939452829 startingPage "1053" @default.
• W2939452829 abstract "BACKGROUND: The C-159T polymorphism of the CD14 receptor gene can be associated with the development of atopic dermatitis. Probiotics can modulate chronic inflammation through activation of the CD14 receptor. So, the efficacy of probiotic therapy can be dependent on this genetic polymorphism.&#x0D; AIM: The purpose of the study was to investigate the efficacy of adding probiotic (Lactobacillus acidophilus, LA-5 and Bifidobacterium animalis subsp. lactis, ВВ-12) to standard treatment (ointment of fluticasone propionate 0.005% and emollient) of atopic dermatitis in adults during 28 days, depending on the stratification of patients on CC or TT genotypes of the CD14 receptor gene.&#x0D; MATERIAL AND METHODS: The study included 37 adult patients with AD. There were identified 19 patients with exogenous (IgE-dependent) and 18 with endogenous (IgE-dependent) AD. To evaluate the efficacy of the probiotics all patients were divided into three groups for both exogenous and endogenous AD. The first group was selected from patients with CC genotype (C-159T) who received standard therapy (ointment of fluticasone propionate 0.005% – 2 times a day, emollients – 2 times a day) and probiotic (Lactobacillus acidophilus, LA-5 and Bifidobacterium animalis subsp. lactis, ВВ-12 - 1 capsule 2 times per day) The second group included patients with CC genotype, who received only standard therapy. The third group was presented by patients with TT genotype (C-159T) who received standard therapy and probiotic. The SCORAD and DLQI parameters were evaluated on Day 0, 14 and 28. The level of IL-4, IL-5, IL-10, TGF-β cytokines was determined on Day 0 and Day 28.&#x0D; RESULTS: The results of our study found that the addition of probiotics (Lactobacillus acidophilus, LA-5 and Bifidobacterium animalis subsp. lactis, ВВ-12) to standard treatment (ointment of fluticasone propionate 0.005%, emollient) significantly increased the effectiveness of treatment of atopic dermatitis in adults with exogenous form and CC genotype (C-159T), confirmed by clinical (a significant decrease of SCORAD and DLQI indices) and immunological criteria (a significant decrease of IL-4 and an increase of TGF-β).&#x0D; CONCLUSION: Simultaneous determination of the exogenous or endogenous form, identification of the C-159T genotypes, evaluation of the serum level of IL-4 and TGF-β can serve as an algorithm for the personalised treatment of patients with atopic dermatitis." @default.
• W2939452829 created "2019-04-25" @default.
• W2939452829 creator A5023127195 @default.
• W2939452829 creator A5064125608 @default.
• W2939452829 creator A5066559239 @default.
• W2939452829 creator A5068050181 @default.
• W2939452829 creator A5080870368 @default.
• W2939452829 date "2019-04-10" @default.
• W2939452829 modified "2023-10-16" @default.
• W2939452829 title "Efficacy of Probiotic Therapy on Atopic Dermatitis in Adults Depends on the C-159T Polymorphism of the CD14 Receptor Gene - A Pilot Study" @default.
• W2939452829 cites W1969715787 @default.
• W2939452829 cites W1981859401 @default.
• W2939452829 cites W1982023818 @default.
• W2939452829 cites W1996035491 @default.
• W2939452829 cites W1996660404 @default.
• W2939452829 cites W1998164631 @default.
• W2939452829 cites W2030298480 @default.
• W2939452829 cites W2032529020 @default.
• W2939452829 cites W2059008263 @default.
• W2939452829 cites W2067394045 @default.
• W2939452829 cites W2069092884 @default.
• W2939452829 cites W2103403520 @default.
• W2939452829 cites W2110094374 @default.
• W2939452829 cites W2120668587 @default.
• W2939452829 cites W2124506539 @default.
• W2939452829 cites W2134119906 @default.
• W2939452829 cites W2139101166 @default.
• W2939452829 cites W2149187544 @default.
• W2939452829 cites W2305795634 @default.
• W2939452829 cites W2516811335 @default.
• W2939452829 cites W2528799484 @default.
• W2939452829 cites W2801208468 @default.
• W2939452829 cites W2906019120 @default.
• W2939452829 cites W2910643610 @default.
• W2939452829 cites W2999891564 @default.
• W2939452829 doi "https://doi.org/10.3889/oamjms.2019.242" @default.
• W2939452829 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6490491" @default.
• W2939452829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31049080" @default.
• W2939452829 hasPublicationYear "2019" @default.
• W2939452829 type Work @default.
• W2939452829 sameAs 2939452829 @default.
• W2939452829 citedByCount "4" @default.
• W2939452829 countsByYear W29394528292020 @default.
• W2939452829 countsByYear W29394528292022 @default.
• W2939452829 countsByYear W29394528292023 @default.
• W2939452829 crossrefType "journal-article" @default.
• W2939452829 hasAuthorship W2939452829A5023127195 @default.
• W2939452829 hasAuthorship W2939452829A5064125608 @default.
• W2939452829 hasAuthorship W2939452829A5066559239 @default.
• W2939452829 hasAuthorship W2939452829A5068050181 @default.
• W2939452829 hasAuthorship W2939452829A5080870368 @default.
• W2939452829 hasBestOaLocation W29394528291 @default.
• W2939452829 hasConcept C100544194 @default.
• W2939452829 hasConcept C104317684 @default.
• W2939452829 hasConcept C126322002 @default.
• W2939452829 hasConcept C135763542 @default.
• W2939452829 hasConcept C203014093 @default.
• W2939452829 hasConcept C207480886 @default.
• W2939452829 hasConcept C2777221637 @default.
• W2939452829 hasConcept C2777697326 @default.
• W2939452829 hasConcept C2777945686 @default.
• W2939452829 hasConcept C2778329239 @default.
• W2939452829 hasConcept C2780206646 @default.
• W2939452829 hasConcept C2780255968 @default.
• W2939452829 hasConcept C2780305828 @default.
• W2939452829 hasConcept C31903555 @default.
• W2939452829 hasConcept C523546767 @default.
• W2939452829 hasConcept C54355233 @default.
• W2939452829 hasConcept C55493867 @default.
• W2939452829 hasConcept C71924100 @default.
• W2939452829 hasConcept C76252995 @default.
• W2939452829 hasConcept C86803240 @default.
• W2939452829 hasConcept C90924648 @default.
• W2939452829 hasConceptScore W2939452829C100544194 @default.
• W2939452829 hasConceptScore W2939452829C104317684 @default.
• W2939452829 hasConceptScore W2939452829C126322002 @default.
• W2939452829 hasConceptScore W2939452829C135763542 @default.
• W2939452829 hasConceptScore W2939452829C203014093 @default.
• W2939452829 hasConceptScore W2939452829C207480886 @default.
• W2939452829 hasConceptScore W2939452829C2777221637 @default.
• W2939452829 hasConceptScore W2939452829C2777697326 @default.
• W2939452829 hasConceptScore W2939452829C2777945686 @default.
• W2939452829 hasConceptScore W2939452829C2778329239 @default.
• W2939452829 hasConceptScore W2939452829C2780206646 @default.
• W2939452829 hasConceptScore W2939452829C2780255968 @default.
• W2939452829 hasConceptScore W2939452829C2780305828 @default.
• W2939452829 hasConceptScore W2939452829C31903555 @default.
• W2939452829 hasConceptScore W2939452829C523546767 @default.
• W2939452829 hasConceptScore W2939452829C54355233 @default.
• W2939452829 hasConceptScore W2939452829C55493867 @default.
• W2939452829 hasConceptScore W2939452829C71924100 @default.
• W2939452829 hasConceptScore W2939452829C76252995 @default.
• W2939452829 hasConceptScore W2939452829C86803240 @default.
• W2939452829 hasConceptScore W2939452829C90924648 @default.
• W2939452829 hasIssue "7" @default.
• W2939452829 hasLocation W29394528291 @default.
• W2939452829 hasLocation W29394528292 @default.
• W2939452829 hasLocation W29394528293 @default.

• next